These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14975601)

  • 1. Immunomonitoring measures in relapsing-remitting multiple sclerosis.
    Matsui M; Araya SI; Wang HY; Matsushima K; Saida T
    J Neuroimmunol; 2004 Mar; 148(1-2):192-9. PubMed ID: 14975601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura].
    Wang TT; Zhao H; Ren H; Guo JH; Xu MQ; Yang RC; Han ZC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):669-73. PubMed ID: 16681922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
    Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
    Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines.
    Sega S; Wraber B; Mesec A; Horvat A; Ihan A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):255-8. PubMed ID: 15177779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
    Krakauer M; Sorensen PS; Sellebjerg F
    J Neuroimmunol; 2006 Dec; 181(1-2):157-64. PubMed ID: 17081623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
    Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term sequential analysis of sex hormones and helper T cells type 1 (Th1) and helper T cells type 2 (Th2) cytokines during and after multiple sclerosis relapse.
    de Andrés C; Rodríguez-Sáinz MC; Muñoz-Fernández MA; López-Lazareno N; Rodríguez-Mahou M; Vicente A; Fernández-Cruz E; Sánchez-Ramón S
    Eur Cytokine Netw; 2004; 15(3):197-202. PubMed ID: 15542443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
    Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
    Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
    Gausling R; Trollmo C; Hafler DA
    Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis.
    Sepulcre J; Sanchez-Ibarrola A; Moreno C; de Castro P
    Cytokine; 2005 Oct; 32(2):111-6. PubMed ID: 16246570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
    Dressel A; Vogelgesang A; Brinkmeier H; Mäder M; Weber F
    J Neuroimmunol; 2006 Dec; 181(1-2):133-40. PubMed ID: 17084909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
    Peng X; Jin J; Giri S; Montes M; Sujkowski D; Tang Y; Smrtka J; Vollmer T; Singh I; Markovic-Plese S
    J Neuroimmunol; 2006 Sep; 178(1-2):130-9. PubMed ID: 16870268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
    Karakantza M; Theodorou GL; Meimaris N; Mouzaki A; John E; Andonopoulos AP; Maniatis A
    Ann Hematol; 2004 Nov; 83(11):704-11. PubMed ID: 15300407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
    Haegele KF; Stueckle CA; Malin JP; Sindern E
    J Neuroimmunol; 2007 Feb; 183(1-2):168-74. PubMed ID: 17084910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.